These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14653123)
1. [Serum nitric oxide and D-dimer before and after administering antihypertensive drugs in essential hypertension]. Zhang WR; Sun M; Luo JK Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):382-4. PubMed ID: 14653123 [TBL] [Abstract][Full Text] [Related]
2. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527 [TBL] [Abstract][Full Text] [Related]
3. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia]. Ponikowski P; Hańczycowa H; Sebzda T; Jurga M; Spring A; Rotter A; Jordanek P Wiad Lek; 1993 Apr; 46(7-8):250-4. PubMed ID: 7902632 [TBL] [Abstract][Full Text] [Related]
4. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension. Pronko TP; Zinchuk VV Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724 [TBL] [Abstract][Full Text] [Related]
5. [Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment]. Zhang WR; Chen BM; Xiong Y; Tao LJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):57-9. PubMed ID: 15871189 [TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366 [TBL] [Abstract][Full Text] [Related]
7. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension. Donmez G; Derici U; Erbas D; Arinsoy T; Onk A; Sindel S; Hasanoglu E Jpn J Physiol; 2002 Oct; 52(5):435-40. PubMed ID: 12533248 [TBL] [Abstract][Full Text] [Related]
8. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
9. [Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention]. Yang C; Li YL; Fang J; Zhang X; Liu HP; Qin XH; Xu XP Zhonghua Nan Ke Xue; 2009 May; 15(5):441-4. PubMed ID: 19514558 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254 [TBL] [Abstract][Full Text] [Related]
11. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation. Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106 [TBL] [Abstract][Full Text] [Related]
12. [The quality of life of hypertensive patients treated with prazosin (sustained-release) or enalapril: a randomized controlled trial over 24 weeks]. Consoli SM; Troy S; Bernaud C Therapie; 2000; 55(2):259-67. PubMed ID: 10967698 [TBL] [Abstract][Full Text] [Related]
13. Effect of losartan therapy on endothelial function in hypertensive patients. Sosa-Canache B; Hernández-Hernández R; Armas-Padilla MC; Armas-Hernández MJ; Cammarata-Segura R; Pacheco B; Guerrero J; Israili ZH; Valasco M Am J Ther; 2007; 14(2):166-71. PubMed ID: 17414585 [TBL] [Abstract][Full Text] [Related]
14. Targeting endothelial dysfunction in hypertensive subjects. Thuillez C; Richard V J Hum Hypertens; 2005 Jun; 19 Suppl 1():S21-5. PubMed ID: 16075029 [TBL] [Abstract][Full Text] [Related]
15. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354 [TBL] [Abstract][Full Text] [Related]
16. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy. Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177 [TBL] [Abstract][Full Text] [Related]
17. Prescribing and usage patterns of two antihypertensive agents: a comparison of terazosin and enalapril. Toiber F; Murthy VS Hosp Formul; 1991 Oct; 26(10):811-3, 817-8. PubMed ID: 10136554 [TBL] [Abstract][Full Text] [Related]
18. [Effect of antihypertensive agents on plasma endothelin, nitric oxide and so on in essential hypertension]. Chen S; Liu G; Yang T Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):587-90. PubMed ID: 10436966 [TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial. Hermida RC; Ayala DE; Khder Y; Calvo C Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247 [TBL] [Abstract][Full Text] [Related]
20. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Miller AL Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]